Cargando…
Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study
BACKGROUND: Canine hemangiosarcoma (HSA) is an aggressive cancer arising from multipotential bone marrow-derived stem cells. Anthracycline chemotherapy drugs have been the mainstay adjuvant chemotherapy following surgery with only modest improvement in survival and an attendant risk for adverse even...
Autores principales: | Lucroy, Michael D., Clauson, Ryan M., Suckow, Mark A., El-Tayyeb, Ferris, Kalinauskas, Ashley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672887/ https://www.ncbi.nlm.nih.gov/pubmed/33208160 http://dx.doi.org/10.1186/s12917-020-02675-y |
Ejemplares similares
-
Field safety experience with an autologous cancer vaccine in tumor-bearing cats: a retrospective study of 117 cases (2015–2020)
por: Lucroy, Michael D, et al.
Publicado: (2021) -
Actionable mutations in canine hemangiosarcoma
por: Wang, Guannan, et al.
Publicado: (2017) -
Constitutive expression and roles of interleukin-8 in canine hemangiosarcoma
por: Kim, Jong-Hyuk, et al.
Publicado: (2013) -
Canine hemangiosarcoma in a female Jindo dog
por: Mun, Ahlyum, et al.
Publicado: (2011) -
Tumor-associated macrophages in canine visceral hemangiosarcoma
por: Kerboeuf, Mikael, et al.
Publicado: (2023)